Pricing Log in Create free account

ANIXA BIOSCIENCES INC (ANIX) vs Immunic, Inc. (IMUX)

ANIXA BIOSCIENCES INC and Immunic, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Immunic, Inc. are of similar size ($96.9M and $96.7M). Across the 8 metrics below, ANIXA BIOSCIENCES INC leads on 5 and Immunic, Inc. on 3.

Valuation

Metric ANIX IMUX Biotechnology median
P/E n/m n/m 8.50
P/S 93.90 n/m 9.71
P/B 6.91 2.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 83.50 n/m 9.21
Earnings yield (11.99%) (62.84%) (33.15%)
Free cash flow yield (8.04%) (29.71%) (25.50%)

Profitability

Metric ANIX IMUX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.57%) (138.17%) (56.36%)
Return on assets (63.45%) (101.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX IMUX Biotechnology median
Revenue growth (TTM) (34.10%) — 6.02%
EPS growth (last fiscal year) 12.82% 38.00% 30.26%
Revenue growth, 5-year CAGR (6.89%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 5.05 4.72
Net debt to EBITDA 1.29 0.15 0.96

Dividend

Metric ANIX IMUX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANIX IMUX Biotechnology median
Market cap 96.65m 96.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack